FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, particularly to an oral preparation, possessing antihypoxic, nootropic and hypolipidemic action. The oral preparation possessing antihypoxic, nootropic and hypolipidemic action contains a combination of vinpocetine and gingko extract in the relation of 1:(3.5 -16).
EFFECT: preparation possesses the pronounced antihypoxic, nootropic and hypolipidemic action.
2 cl, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
COMBINED REMEDY FOR IMPROVING THE FUNCTIONAL STATE OF THE BRAIN | 2021 |
|
RU2782672C1 |
PHARMACEUTICAL COMPOSITION POSSESSING CEREBROVASODILATING AND NOOTROPIC ACTIVITY | 2003 |
|
RU2262931C2 |
PHARMACEUTICAL COMPOSITION IN FORM OF SOLUTION FOR INJECTIONS, POSSESSING CEREBROVASODILATING AND NOOTROPIC ACTIVITY, AND METHOD OF ITS RECEPTION | 2007 |
|
RU2359669C1 |
COLLECTION OF HERBS OF NOOTROPIC ACTION | 2020 |
|
RU2740897C1 |
EUFRAZINE, MEDICINAL HERB TEA POSSESSING ANTIOXIDANT AND NOOTROPIC ACTIVITY | 2014 |
|
RU2560077C1 |
STRESS-PROTECTIVE AGENT SHOWING ANTIAMNESTIC, ANTIHYPOXIC, ANXIOLYTIC AND ANTI-SHOCK-PRODUCING ACTIONS | 1992 |
|
RU2064793C1 |
MEDICINAL AGENT POSSESSING NOOTROPIC ACTIVITY (VARIANTS) | 2006 |
|
RU2322240C1 |
PHARMACEUTICAL COMPOSITION POSSESSING WITH NOOTROPIC EFFECT | 2004 |
|
RU2276992C2 |
COMPOSITION FOR IMPROVING CEREBRAL CIRCULATION | 2002 |
|
RU2222318C2 |
QUINAZOLINE DERIVATIVES, POSSESSING NOOTROPIC AND ANTIHYPOXIC ACTIVITY | 2012 |
|
RU2507198C1 |
Authors
Dates
2013-12-10—Published
2011-11-24—Filed